Justices Won't Review Drug Exec's $1.4M Tax Penalty
By David Hansen · June 20, 2023, 6:57 PM EDT
A former pharmaceutical executive lost his last chance to reduce a $1.4 million penalty for failing to report a foreign bank account when the U.S. Supreme Court declined on Tuesday to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login